Product Information

GVOKE 1 MG/0.2 ML KIT is a brand product labeled by Xeris Pharmaceuticals, Inc., priced at $1598.1000 per ML under NDC 72065014011. Its NADAC has been published 106 times since Jun 19, 2024.

GVOKE 1 MG/0.2 ML KIT

glucagon injection, solution
$1598.1000per ML

Strength

1 mg/.2mL

NDC

72065014011

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

6/17/2026

Active Ingredients

GLUCAGON

Approval Type

New Drug (NDA)

FDA Application

NDA212097

On Market Since

10/11/2021

Pharmacological Classes

Antihypoglycemic Agent
Decreased GI Motility
Decreased GI Smooth Muscle Tone
Decreased Glycolysis
Gastrointestinal Motility Inhibitor
Increased Gluconeogenesis
Increased Glycogenolysis

Price Statistics

The NADAC for GVOKE 1 MG/0.2 ML KIT has been published 106 times since Jun 19, 2024, and over the history we have for it it has risen 5.2%. The table below summarizes its recorded NADAC range and movement.

Current price$1598.1000 per ML
All-time high$1603.8017 (Jun 10, 2026)
All-time low$1516.3159 (Nov 20, 2024)
52-week high$1603.8017
52-week low$1545.1227
Median price$1556.5682
Average price$1553.1812
Largest weekly change+3.0% (Feb 12, 2025)
Weeks tracked106
Tracking sinceJun 19, 2024

Price History

1W

0.0%

1M

-0.4%

3M

-0.4%

6M

+2.7%

1Y

+3.3%

3Y

N/A

5Y

N/A

All

+5.2%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 0%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of GVOKE 1 MG/0.2 ML KIT?

The current National Average Drug Acquisition Cost (NADAC) for GVOKE 1 MG/0.2 ML KIT, manufactured by Xeris Pharmaceuticals, Inc., is $1598.1000 per ML (NDC 72065014011), effective Jun 24, 2026.

How has the price of GVOKE 1 MG/0.2 ML KIT changed over time?

Over the history we have for it, the NADAC for GVOKE 1 MG/0.2 ML KIT has risen 5.2%. It has been tracked across 106 weekly CMS publications since Jun 19, 2024.

What are the highest and lowest recorded NADAC prices for GVOKE 1 MG/0.2 ML KIT?

Since Jun 19, 2024, the NADAC for GVOKE 1 MG/0.2 ML KIT has ranged from a low of $1516.3159 (Nov 20, 2024) to a high of $1603.8017 (Jun 10, 2026), with a median of $1556.5682 per ML.

Are there cheaper alternatives to GVOKE 1 MG/0.2 ML KIT?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, GVOKE HYPOPEN 2-PK 1 MG/0.2 ML, is $1597.9517 per ML — about 0% below GVOKE 1 MG/0.2 ML KIT.

Who manufactures GVOKE 1 MG/0.2 ML KIT?

GVOKE 1 MG/0.2 ML KIT (NDC 72065014011) is labeled by Xeris Pharmaceuticals, Inc., and CMS classifies it as a brand product.